Fig. 1From: Effect of etelcalcetide on cardiac hypertrophy in hemodialysis patients: a randomized controlled trial (ETECAR-HD)Study flow chart. cMRI cardiac magnetic resonance, Echo echocardiography, FGF23 fibroblast growth factor 23, RAAS renin–angiotensin–aldosterone systemBack to article page